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Introduction
Genotype-phenotype correlation is still challenging in
FMF patients especially when the disease is part of a
complex autoinflammatory disease.
Case report
A 23-year-old female was diagnosed for FMF in 2002 after
a 3-year course of recurrent atypical attacks. Administra-
tion of colchicine 1mg was started and symptoms
improved.
In 2005 she developed fever and epilepsy. CT-scans
demonstrated splenic and cerebral lesions of uncertain
etiology. Autoantibodies tests were negative. Infectious
diseases were ruled out and therapy with steroids and car-
bamazepine was started under suspicious of vasculitis.
Patient improved and in 2006 brain MRI showed resolu-
tion of cerebral lesions. She tapered steroids, gave up car-
bamazepine and was well under colchicine 1mg with rare
mild FMF attacks but no signs of amyloidosis. She got
pregnant in 2012. During pregnancy she experienced
several mild FMF attacks with slight improvement despite
colchicine increasing to 1.5mg. She developed gestosis.
Her delivery was complicated by big vaginal hematoma
that was surgically drained in two subsequent times.
Further investigations on haemophilic acquired diseases
were negative as well as platelets functional tests.
DNA sequence analysis did not find classic MEFV muta-
tions and revealed heterozygosity for a novel c.460T>C in
exon 2 , leading to the replacement of a polar Serine by an
hydrophobic Proline at amino acid position 154 (S154P),
not reported in Infevers database. This nucleotide substi-
tution was not present in the genomic DNA of 734 control
chromosomes. No mutations of the exons 2 and 11 of the
Mevalonate Kinase gene and the exons 2,3,4 and 6 of the
TNFRSF1A gene were found The woman was found to be
heterozygous for the c.362G>A in the exon 4 (R92Q). Her
father is heterozygous for the R92Q low penetrance var-
iant in the TNFRSF1A gene, while her mother is heterozy-
gous for the S154P mutation in the MEFV gene; both the
parents do not report any inflammatory attack and are
asymptomatic for autoinflammatory syndromes.
Discussion
About 200 MEFV gene mutations have been described so
far in patients with FMF. Recently it has been shown that
in up to 25% of the patients, one MEFV mutation is prob-
ably enough to manifest the disease. This behavior could
be explained assuming an interaction between the single
MEFV mutation with another mutated inflammatory gene.
R92Q is considered a low penetrance TNFRSF1A muta-
tion that has been found to have a population frequency
between 2-5%. The role of the R92Q has not been wholly
understood. Given the fact that the carrier rates for R92Q
are very similar and do not significantly differ from the
carrier rate in controls, it might be concluded that an
interaction between TNFRSF1A and MEFV is minimal or
does not exist. A number of patients with heterozygous
mutations in two autoinflammatory genes have been
described so far in MEFV-TNFRSF1A, MVK-TNFRSF1A,
and CIAS1-MEFV. The scarcity of such patients provides
support to the conclusion that these autoinflammatory
genes do not interact.
Based on the notion that some individuals who harbour
only one mutation may have the second hit in currently
unrecognized autoinflammatory genes, a whole-exome
sequencing in selected cases may be performed.
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